Entera Bio Ltd.
ENTX · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 3 ·
Latest disclosures
-
Camisasca Riccardo Paolo: Form 3
Insider disclosure · Filed · Report period 18 Aug 2026
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ENTX · M40527109 - Ordinary Shares, par value of NIS 0.0000769
Company details and SEC sources
CIK 0001638097 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ENTX on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, 9112002
- Incorporated in
- Israel
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields